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Purpose: To investigate the effect of chitosan (CS) salt forms and pH condition on the transepithelial 
electrical resistance (TEER) of Caco-2 cell monolayer for enhanced permeability.  
Methods: Solutions (2 %w/v) of four different salt forms of CS-aspartate (CS-A), CS-ethylene diamine 
tetraacetate (CS-EDTA), CS-hydroxybenzotriazole (CS-HOBt) and CS-thiamine pyrophosphate (CS-
TPP) - were prepared and tested on TEER using fluorescein isothiocyanate dextran 4,400 (FD-4) as the 
permeant across Caco-2 cell monolayer in both pH 6.2 and 7.4 (physiological pH) environment.  
Results: The results show that CS-salt solutions, at pH of 6.2, increased cell permeability in a dose-
dependent manner and caused relatively reversible effects only at low doses of 0.001 - 0.010 %w/v. At 
CS-salt solution concentration of 0.01 %w/v, accumulation of FD-4 in the acceptor compartment was in 
the rank order: CS-EDTA > CS-TPP > CS-A > CS-HOBt. All CS-salt solutions significantly (p < 0.05) 
increased the transport of FD-4. On the other hand, at pH 7.4, only CS-EDTA at a concentration of 0.5 
%w/v enhanced the transport of FD-4. CS-EDTA was also the most toxic CS salt.  
Conclusion: The salt forms of CS are capable of enhancing the transport of FD-4 across Caco-2 cell 
monolayer, with CS-EDTA the most promising of them. 
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Chitosan (CS) is used as a novel carrier of drugs 
for oral and intravenous administration. It has 
been documented that chitosan enhances drug 
absorption across intestine into blood in animals 
[1]. CS is a polycationic polymer at acidic pH with 
numerous applications in the food, agricultural, 
cosmetic and pharmaceutical industries. 
Advantages of this polymer include high 
availability, low cost, high biocompatibility, 
biodegradability, and ease of chemical 
modification.  
 
In many studies, it has been demonstrated that 
CS-based formulations are superior in enhancing 
absorption of therapeutic proteins. CS is soluble, 
mucoadhesive and effective as an absorption 
enhancer only in its protonated form [2]. 
Functional groups (amine and hydroxyl) are 
present in CS, and various chemical chitosan 
derivatives have been synthesized and studied 
for different applications. However, chemical 
modification of chitosan normally utilizes strong 
organic solvent that might be residual in the 
product and/or in the medium. Among water 
soluble CS, CS-salts are easier to prepare and 
have no need for organic solvent, acid or heat. 
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CS-salts are soluble in water and exhibit 
favorable biological properties such as non-
toxicity, biocompatibility and biodegradability. 
They have attracted much interest in 
pharmaceutical research as polymeric drug 
carriers and as a novel drug absorption enhancer 
across nasal and intestinal epithelium [3,4].  
 
Although, CS-salts have been reported to be 
used for biomedical applications such as drug 
and protein delivery, and transfection of 
DNA/siRNA [5,6], some CS-salts such as 
ethylenediaminetetraacetic acid (EDTA), 
hydroxybenzotriazole (HOBt), and thiamine 
pyrophosphate (TPP) have not yet been 
investigated for absorption enhancement. EDTA 
is well known as a metal chelator and widely 
used in textile, food, and pharmaceutical 
industries, while, HOBt (a derivative of 
benzotriazole) is used to improve efficiency of 
peptide synthesis. TPP is a thiamine derivative. It 
is a coenzyme present in all living systems where 
it catalyzes several biochemical reactions [7]. 
 
Therefore, the objective of the present study was 
to evaluate CS-salts solution of EDTA, HOBt, 
and TPP for their in vitro absorption 
enhancement on transepithelial electrical 
resistance (TEER) and permeability of Caco-2 
cells monolayers by using FITC-dextran (FD-4) 
as a model hydrophilic drug macromolecule; a 
secondary objective was to compare their 
cytotoxicity with that of CS aspartate which has 






Chitosan (degree of deacetylation 0.85, MW 110 
kDa), aspartic acid, ethylene diamine 
tetraacetate (EDTA), thiamine pyrophosphate 
(TPP), hydroxybenzotriazole monohydrate 
(HOBt·H2O), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT), fluorescein 
isothiocyanate dextran 4,400 (FD-4) were 
purchased from Sigma-Aldrich Chemical Co. 
(MO, USA). Dulbecco’s modified Eagle’s medium 
(DMEM), trypsin-EDTA, fetal bovine serum 
(FBS), glutamine, sodium pyruvate and penicillin-
streptomycin antibiotic were obtained from 
Gibco-Invitrogen (NY, USA).  Caco-2 cell line 
was obtained from American Type Culture 
Collection (Rockville, MD, USA). 
 
Preparation of chitosan salts  
 
Chitosan (CS) salts prepared from four acids: 
aspartic acid, ethylene diamine tetraacetate, 
thiamine pyrophosphate and hydroxybenzo-
triazole. The method used was as described in a 
previous report [9]. Briefly,  2 %w/v of CS-salt 
solution was prepared by simply mixing the 
chitosan and the acids in water overnight at a 
ratio of 1:1 for chitosan thiamine pyrophosphate 
(CS-TPP) and chitosan hydroxybenzotriazole 
(CS-HOBt), 2:1 for chitosan ethylene diamine 
tetraacetate (CS-EDTA) and 1.5:1 for chitosan 
aspartate (CS-A). After mixing, the pH of the CS-
salt solution was adjusted to 6.2 or 7.4 with 1N 
HCl or 1N NaOH, and centrifuged to separate 
precipitants. The precipitants were lyophilized in 
a freeze-dryer (Labconco, Freezone 2.5, USA) 




Caco-2 cells were maintained in Dulbecco's 
modified Eagle's medium (DMEM) at pH 7.4, 
supplemented with 10 % fetal bovine serum, 2 
mM L-glutamine, 1 mM sodium pyruvate, 1 % 
non-essential amino acid solution, 0.1 % 
penicillin-streptomycin in a humidified 
atmosphere (5 % CO2, 95 % air, 37 C). The 
cells were grown under standard conditions until 
60 – 70 % confluency. Routine passing of cell 
stocks was carried out in 75-cm2 flasks. Cells 
from passages 35 - 45 were used for all 
experiments.  
 
Measurement of trans-epithelial electrical 
resistance (TEER) 
 
The cells were seeded on tissue culture 
polycarbonate membrane filters (pore size, 3.0 
µm) in 12-well Transwell® plates (Corning Life 
Sciences (Massachusetts, USA). at a seeding 
density of 6 x 104cells/cm2. The culture medium 
was added to both the donor and the acceptor 
compartments and the medium changed every 
second day. The cells were left to differentiate for 
3 weeks after seeding with monitoring of trans-
epithelial electrical resistance (TEER) values of > 
600 .cm2 using a Millicell ERS meter 
(Millipore, Bedford, MA, USA). Solutions of each 
of the four CS-salts (0.001 – 1 % w/v) were 
prepared in Hank’s balanced salt solution 
(HBSS) buffered at the same pH as the CS-salt 
solutions (6.2 and 7.4). One hour before the start 
of each experiment, the cells were washed twice 
with phosphate buffered saline (PBS) and pre-
equilibrated with HBSS buffered at pH 7.4. After 
removing the medium, the Caco-2 cell 
monolayers were treated with CS-salt solution 
(0.001 – 1 % w/v) at apical compartment. TEER 
was measured every 20 min. After 2 h treatment, 
the cells were carefully washed twice with PBS 
and incubated with a fresh culture medium. 
Recovery of TEER values was monitored for 48 
h after treatment. Control experiments, without 
Kowapradit et al 
Trop J Pharm Res, August  2013;12 (4): 
 
497 
CS-salt solutions, were done under the same 
conditions. Experiments were carried out in 
triplicate at 37 ºC in an atmosphere of 95 % air 
and 5 % CO2. Resistance was expressed as 
%TEER of initial value. 
 
Transport studies  
 
The transport of FD-4 across the Caco-2 cell 
monolayer was carried out on Caco-2 
monolayers grown in Transwell (12-well) plates 
when they had differentiated and the monolayer 
was intact, as checked by measuring TEER. 
Prior to the experiment, the cells were washed 
twice with PBS and pre-equilibrated for 1 h with 
HBSS buffered at pH 7.4. After removing the 
medium, the cells were treated with CS-salt 
solutions at the recovered cell concentration 
(0.01 %w/v for pH 6.2 and 0.5 – 1 %w/v for pH 
7.4) at apical compartment for 2 h. In the control 
wells, the same media  but without CS-salt 
solutions were used. In all cases, the basolateral 
medium used was Hanks' balanced salt 
solution (HBSS, pH 7.4). After 2 h treatment, the 
cells were carefully washed twice with PBS and 
FD-4 solution (1 mg/ml) was added on the apical 
side of the monolayers. Since FD-4 is a 
negatively charged polymer, the aggregation 
would form strong electrostatic interactions with 
the positively charged CS. Therefore, FD-4 was 
added after CS-salts solution incubation. 
Samples (1000 µl) were taken under sink 
conditions at 30, 60, 90, 120, 180 and 240 min 
from the basolateral side and replaced with an 
equal volume of fresh HBSS solution. The 
amount of FD-4 was determined using a 
fluorescence 96-wells plate reader (Universal 
Microplate Analyzer, Model AOPUS01 and 
AI53601, Packard BioScience, CT, USA). The 
excitation and emission wavelengths were 400 
and 535 nm, respectively. The results were 
expressed as % cumulative transport as a 
function of time. All experiments were done in 
triplicate at 37 °C. Apparent permeability 
coefficient was calculated according to Eq 1. 
 
Papp =  (dQ/dt)   (1/A Co) …………………. (1) 
 
where Papp is the apparent permeability 
coefficient (cm/s), dQ/dt (μg/s) the rate of 
appearance of FD-4 on the basolateral side, A is 
the surface area of the monolayers, and C0 
(μg/ml) is the initial FD-4 concentration in the 
donor compartment. All rate constants were 
obtained from the permeation profiles of each 
compound. Absorption enhancement ratio (R) 
was calculated from Papp values as in Eq 2 [10]. 
 




The acute cytotoxic effect of CS-salt solutions at 
pH 6.2 and 7.4 on cell viability was measured 
using MTT assay. MTT is a tetrazolium salt 
which is cleaved to a dark blue product by 
mitochondrial dehydrogenases in living but not in 
dead cells [11]. Caco-2 cells used for MTT assay 
were seeded at a density 2  104 cells/well in 96-
well cell culture plates and pre-incubated for 24 h 
before treatment. The cells were then treated 
with CS-salt solutions at various concentrations 
0.001 – 1 %w/v in serum-free medium pH 6.2 
and 7.4 for 24 h. Dilute CS-salt solutions was 
made by using serum-free medium to ensure that 
the cells did not die from nutrition deficiency.  
After treatment, CS-salt solution was removed 
and fresh cell culture medium was added and 
incubated for 4 h to stabilize the cells. Finally, the 
cells were incubated with 100 l MTT containing 
medium (0.1 mg/ml MTT in serum-free medium) 
for 4 h. The medium was removed, and the 
formazan crystal formed in living cells was 
dissolved in 100 l DMSO per well. Relative cell 
viability (V, %) was calculated based on 
absorbance at 550 nm (Eq 3) using a microplate 
reader (Universal Microplate Analyzer, model 
AOPUS01 and AI53601, Packard BioScience, 
CT, USA). Viability of non-treated control cells 
was arbitrarily defined as 100 %. 
 
V (%) = {(As – Ab)/Ac – Ab)}100 ………… (3) 
where As, Ab and Ac are the absorbance of the 
test sample, blank and control, respectively. 
 
Statistical analysis  
 
All experimental measurements were made in 
triplicate and values expressed as mean  
standard deviation (SD). Statistical significance 
of differences in permeability enhancement and 
cell viability were examined using one-way 
analysis of variance (ANOVA) followed by LSD 





Effect of chitosan salts on TEER  
 
The effect of different CS salt forms and 
concentrations on TEER of Caco-2 cell 
monolayers is summarized in Figs 1 - 4. 
Incubation on the apical side of the monolayers 
with 0.001 – 1 %w/v of the CS-salt solutions at 
pH of 6.2 for 2 h resulted in immediate reduction 
in TEER values compared with control group. 
The reduction was concentration-dependent with 
increase in salt concentration resulting in 
significant decrease (p < 0.05) in TEER 
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compared with control. After removal of CS-salt 
solutions, recovery of the treated cells was 
monitored for TEER for 48 h, and the results 
show increase in resistance CS-salt 
concentrations of 0.001 - 0.01 %w/v. with TEER 
recovery of > 60 % of initial values within 24 h of 
CS-salt solution removal from the cells, indicating 
that the effect of CS-salt was reversible at lower 
concentrations. Drug transport studies were 
therefore investigated at a concentration of 0.01 
%w/v, being the safest and most effective 
enhancer concentration (Fig 1, 2).   
 
Figure 1: Effect of (a) CS-A, (b) CS-EDTA at 
concentrations ranging from 0.001 - 1 %w/v, at pH 6.2 
on TEER (left) and TEER recovery (right) of Caco-2 
cell monolayers. Key: () control, (■) 0.001 %w/v, (▲) 
0.01 %w/v, () 0.05 %w/v, ( ) 0.1 %w/v, () 1 %w/v.  
Each point represents the mean of three experiments; 
* p < 0.05 
 
Figure 2: Effect of (a) CS-HOBt, (b) CS-TPP at 
concentrations ranging from 0.001 - 1 %w/v, at pH 6.2 
on TEER (left) and TEER recovery (right) of Caco-2 
cell monolayers. Key: () control, (■) 0.001 %w/v, (▲) 
0.01 %w/v, () 0.05 %w/v, ( ) 0.1 %w/v, () 1 %w/v.  
Each point represents the mean of three experiments; 
* p < 0.05 
 
At pH of 7.4, incubation on the apical side of the 
monolayer with the CS-salt solutions (0.001 – 1 
%w/v) for 2 h resulted in no significant 
decrease(p < 0.05) in TEER for CS-A and CS-
TPP (Fig 3), but for CS-EDTA and CS-HOBt, 
there was concentration-dependent decrease (p 
< 0.05) in TEER at high concentrations (0.5 – 1 
%w/v for CS-EDTA and 1 %w/v for CS-HOBt). 
After removal of CS-salt solutions, increase in 
resistance towards initial values was found. 
However, cells treated with 1 %w/v CS-EDTA 
solution showed only 50% recovery TEER in 48 
h, indicating that CS-EDTA had a very strong 
effect on the cells (Fig 4).  
 
 
Figure 3: Effect of (a) CS-A and (b) CS-TPP at pH 7.4 
on TEER of Caco-2 cell monolayers. Key: () control, 
(■) 0.001 %w/v, (▲) 0.01 %w/v, () 0.05 %w/v, ( ) 
0.1 %w/v, () 1 %w/v.  Each point represents the 




Figure 4: Effect of (a) CS-EDTA and (b) CS-HOBt at 
pH 7.4 on TEER (left) and TEER recovery (right) of 
Caco-2 cell monolayers. Key: () control, (■) 0.001 
%w/v, (▲) 0.01 %w/v, () 0.05 %w/v, ( ) 0.1 %w/v, 
() 0.5 %w/v, () 1 %w/v.  Each point represents the 
mean of three experiments; * p < 0.05 
 
Effect of chitosan salts on transport of FD-4  
 
Fig 5a shows the transport of FD-4 across the 
Caco-2 cell monolayers in the presence of CS-
salt solutions at a concentration of 0.01 %w/v at 
pH 6.2 and in the absence of CS (control). 
Incubation with CS-salts resulted in accumulation 
of FD-4 in the acceptor compartment. All CS-salt 
solutions significantly increased (p < 0.05) 
transport of FD-4 unlike control which did not. 
These results correlate with TEER reduction 
data. On the other hand, at pH 7.4 incubation, 
CS-EDTA produced the highest increase in 
transport of FD-4 while CS-HOBt did not 
significantly increase transport of FD-4, even at a 
concentration of 1 %w/v (Fig 5b). Cumulative 
transport   of   FD-4, Papp,   data  and  absorption  
Kowapradit et al 




Figure 5: Cumulative transport of FD-4 in the presence of 0.01 %w/v CS-salt solutions,at (a) pH 6.2: () CS-A, 
(▲) CS-EDTA, () CS-HOBt, (■) CS-TPP, () A, () EDTA, () HOBt, ( ) TPP and () control; and (b) pH 7.4: 
(▲) 1 %w/v CS-EDTA, () 0.5 %w/v CS-EDTA, () 1 %w/v CS-HOBt () 0.5 %w/v CS-HOBt and () control. 
Each point represents the mean of three experiments; *p < 0.05 
 
Table 1: Effect of CS-salts on the transport of FD-4 (mean ± SD, n = 3) 
Sample pH Conc. (%w/v) 
%Cumulative transport  




Control 6.2 - 6.33±3.70 0.40 1.00 
A 6.2 0.01 6.56±0.10 0.42 1.04 
EDTA 6.2 0.01 8.14±6.10 0.51 0.27 
HOBt 6.2 0.01 3.55±0.60 0.20 0.09 
TPP 6.2 0.01 4.72±0.60 0.29 0.28 
CS-A 6.2 0.01 30.95±4.90 1.89 4.70 
CS-EDTA 6.2 0.01 36.19±13.20 2.19 5.45 
CS-HOBt 6.2 0.01 17.47±3.60 1.04 2.58 
CS-TPP 6.2 0.01 32.22±7.50 1.90 4.74 
Control 7.4 - 4.61±1.90 0.31 1.00 
CS-EDTA 7.4 0.5 39.29±1.80 2.52 8.21 
CS-HOBt 7.4 0.5 3.54±0.20 0.23 0.75 
CS-EDTA 7.4 1 67.01±4.10 3.92 12.80 
CS-HOBt 7.4 1 7.98±1.80 0.50 1.65 
aPapp = apparent permeability coefficient; bR = absorption enhancement ratio 
Table 2: Cytotoxicity of CS salts incubated with Caco-2 cells for 2 and 24 h (mean ± SD, n = 8) 
 
IC50a (%w/v)      Sample Sample pH                2 h            24 h 
CS-A 6.2 >1 0.10 ± 0.03 
CS-EDTA 6.2 0.25 ± 0.06 0.07 ± 0.05 
CS-HOBt 6.2 0.28 ± 0.06 0.15 ± 0.11 
CS-TPP 6.2 0.60 ± 0.06 0.15 ± 0.04 
CS-A 7.4 >1 >1 
CS-EDTA 7.4 0.30 ± 0.05 0.20 ± 0.03 
CS-HOBt 7.4 0.95 ± 0.17 >1 
CS-TPP 7.4 >1 >1 
aIC50 = half maximum inhibitory concentration 
 




The effect of CS-salts on mitochondrial 
dehydrogenase activity was expressed as IC50 
with high value indicating low toxicity (Table 2). 
All the CS-salts tested showed concentration-
dependent cytotoxicity in the Caco-2 cell model 
at pH 6.2, but at pH 7.4, only CS-EDTA showed 
concentration-dependent cytotoxicity. Cytotoxi-
city results varied among the salts used with CS-
EDTA the most toxic (IC50 of 0.25 ± 0.06 and 
0.30 ± 0.05 %w/v at pH 6.2 and 7.4, respectively, 
after 2 h incubation).  
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CS is insoluble at neutral and alkaline pH, but 
forms water soluble salts with inorganic and 
organic acids. CS-salts are soluble in water; their 
solubility being dependent on the degree of 
deacetylation and pH of the solution. Due to the 
positive charge of amine groups in CS structure it 
can be complexed with a negative charge of salt 
by electrostatic interaction. Many salts including 
aspartic acid, EDTA, HOBt and TPP present 
negative charge on their molecules, thus, 
improving CS water solubility and allowing CS to 
be dissolved in water.  
 
TEER measurement can be used to evaluate 
possible damage of cellular monolayer during 
experiments and also tight-junction permeability. 
It measures the ionic permeability of the cell 
monolayer. Increase in the paracellular 
permeability of the cell monolayers shows as 
decrease in TEER. The results indicate that 
incubation with all four CS-salt solutions at pH of 
6.2 decreased TEER but the treated cells fully 
recovered within 48 h after removal of low 
concentration (0.001 - 0.01 %) CS-salt solution, 
indicating that these CS-salt are safe for use as 
absorption enhancers under the applied. These 
results could be confirmed with transport of FD-4 
which showed that the transport of FD-4 across 
the Caco-2 cell monolayers in the presence of 
CS-salt solutions at the concentration of 
0.01%w/v, pH 6.2, resulted in an accumulation of 
FD-4 in the acceptor compartment. A difference 
in the transport of FD-4 was found at different 
CS-salt forms as showed in Fig. 4a and Table 1.   
 
TEER and cytotoxic results could be explained 
by the fact that EDTA, a powerful metal chelating 
agent, might have disrupted cell-cell adhesion by 
depleting the extracellular Ca2+ required for the 
interaction of components of adherens junctions. 
Interactions between components of adherens 
junctions on adjacent epithelial cells maintains 
cell–cell adhesion and thus paracellular space. 
Therefore, chelation of Ca2+ may induce tight 
junction separation by physical disruption of cell–
cell adhesion [12]. The chelation of extracellular 
Ca2+ would also activate intracellular protein 
kinases that induce the disruption of junctional 
integrity. Ca2+ chelators function by activation of 
tyrosine kinases and the subsequent 
phosphotyrosine-regulated increase in paracellu-
lar permeability is effected by cadherin–catenin 
complex that comprises of the adherens junction 
[13]..  
 
Therefore, chelation of Ca2+ would not just 
physically abolish cell–cell adhesion; instead, it 
would specifically activate a signal transduction 
cascade that regulates junctional integrity 
 
In addition, EDTA is soluble at alkaline pH. This 
might be the reason for CS-EDTA to have 
exerted its effect on the cells even at pH 7.4. 
EDTA is one of the best chelation products for 
removal of unwanted metals (in particular, 
calcium, mercury, lead, cadmium, and arsenic) 
from the body’s organs and cardiovascular 
system [14]. It is approved by United States Food 
and Drug Administration (FDA) for this use. 
However, it should be noted that there are 
various types of EDTA. Some are used for 
industrial purposes while others are of food 
and/or pharmaceutical grade for human 
consumption. It is also important to consider the 
method of administering EDTA. It is taken orally 
(liquid, capsule, sublingually), by suppository, 
and through IV. There are varying degrees of 
safety and effectiveness for each route of 
administration.  
 
For most paracellular permeation enhancers, 
there is little difference between their cytotoxicity 
and ability to increase paracellular efficacy. Thus, 
the ability of many enhancers to increase 
paracellular permeability is not a direct result of 
their toxic actions [15].  
 
The cytotoxicity of enhancers is determined by 
several methods. In the present study, two 
methods were employed; MTT assay and TEER 
measurement. MTT is actively absorbed in a 
succinate NADH+ mitochondrial-dependent 
reaction to yield a formazan product. The ability 
of the cells to reduce MTT provides an indication 
of mitochondrial activity that is interpreted as a 
metabolic marker for cell viability. This process 
requires active mitochondria, and even freshly 
dead cells do not cleave significant amounts of 
MTT. A drawback of the assay is that it does not 
distinguish between a cytotoxic (cell kill) and a 
cytostatic (reduced growth rate) effect[11,16]. 
Moreover, MTT assay measures the effect of a 
drug on the growth of a population of cells 
whereas TEER measurement measures the 
effect of a drug on differentiated cells. For these 
reasons, MTT assay seems to be a more 
sensitive indicator of chemical exposure than 
TEER measurement. In fact, MTT model reveals 
that at equivalent IC50, mitochondrial activity is 
more likely to be altered before paracellular 
permeability is compromised. Very often 
researchers use only TEER to estimate the 
possible cytotoxic effects of compound under 
investigation. However, the relationship between 
TEER and cytotoxicity is not very clear and is 
non-linear; above a certain level of TEER, very 
small increases in junctional permeability may 
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produce large decreases in resistance, while at 
low-resistance values relatively large changes in 
transjunctional flux of tracer will often be 
associated with very modest changes in TEER 
[17]. Additionally, decrease in TEER is not 
necessarily predictive of a cytotoxic effect as this 
decrease is reversible. Therefore, the best way 





Among the CS salts evaluated, CS-EDTA is the 
best of absorption enhancer but was also the 
most toxic. In general, CS salts enhanced drug 
absorption across Caco-2 cell monolayers, with 
CS-EDTA in particular demonstrating a potential 
as a good absorption enhancer. 
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